C.N. 176108.8
MANOSAR® Granulated. Oral use.
Food supplement for the proper functioning of the urinary system and the prevention of recurrent UTIs*.
* UTIs: Urinary Tract Infections
Indications:
- Prolonging the effect of the antibiotic in acute episodes of UTI.
- Prevention of recurrent UTI.
- Postcoital cystitis.
The components of MANOSAR® are formulated as a sustained release granule: it releases for 24 hours D-mannose and cranberry proanthocyanidins (PAC), in effective quantities that complement each other in their mechanism of action to prevent recurrences of urinary tract infections. In addition, it includes ursolic acid, zinc and vitamins A, C and E to improve the symptoms of the infection and achieve total patient protection.
ADVANTAGES
- Only product in the market with extended release system of D-mannose.
- Elimination of bacteria through urine.
- Helps urothelium recovery after infection.
- Improves symptomatology.
- Strengthens the immune system.
- Effective dose of D-mannose: 2000 mg.
Suitable for celiacs, diabetics, pregnant and lactating women, salt-free.
COMPOSITION
Content per sachet:
- 2000 mg D-mannose
- 140 mg PAC
- 7.98 mg Ursolic Acid
- 80 mg Vitamin C (100% NRV)
- 12 mg Vitamin E (100% NRV)
- 10 mg Zinc (100% NRV)
- 800 µg Vitamin A (100% NRV)
* NRV: Nutritional Reference Values.
Does not contain gluten, lactose or sucrose.
Suitable for celiacs, diabetics, suitable for pregnant and lactating women, salt free.
POSOLOGY
- To prolong the antibiotic effect in acute episode of UTI: 1 sachet per day for 1 month.
- To prevent recurrent urinary tract infections: 1 sachet per day for at least 3 months.
- For the prevention of postcoital cystitis: 1 sachet after sexual intercourse.
Pour the content of one sachet directly into the mouth, in one or several portions and swallow the granules with a glass of water. Do not chew. It can also be dispersed in yogurt or jelly. Take one sachet preferably before going to bed and after urinating.
MANOSAR® has several studies proving its efficacy:
- RITUMAN study: 283 women with recurrent urinary tract infections.
- Publi-report Dr. Salinas, Head of the Urology Department at the Hospital Clínico San Carlos in Madrid
- MANCOIT STUDY. A pilot study on the prevention of recurrent postcoital UTIs in women using D-mannose and proanthocyanidins (PAC)
Related articles:
- UTI-UAEU treatment protocol.pdf
- Poster. UTI-UAEU treatment protocol.pdf
- The role of D-MANNOSE in the management of UTIs
MANOSAR®, the TOTAL protection against urinary tract infections.